EMD Millipore debuts a new cell-culture media compacting technology that will turn messy, dry powders into granules.
EMD Millipore announced on June 2, 2015 that a new technology from the company may help operators better deal with powder-based cell culture media. The new technology compacts dry-powder cell culture media into granules, which the company says will improve solubility, flowability, and mimimize dust formation to improve handling and cleanliness.
Making powders denser allows for faster dissolution of media, and increased flowability enables better mixing and decreases the chance of media caking, according to the company. EMD Millipore plans to use the compaction technology for customers’ specific process needs, as well as for its own portfolio of cell-culture media products.
“Biopharmaceutical manufacturers need cell-culture media that are highly soluble, homogenous, and convenient to handle,” said Matthias Bucerius, director of global marketing of pharma raw materials, EMD Millipore, in a press release. “We developed our compaction technology to address the market need for dry powder media that reliably meet those requirements.”
Source:
EMD Millipore
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.